C. John Sperati

2.9k total citations
52 papers, 1.3k citations indexed

About

C. John Sperati is a scholar working on Nephrology, Immunology and Molecular Biology. According to data from OpenAlex, C. John Sperati has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 18 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in C. John Sperati's work include Renal Diseases and Glomerulopathies (21 papers), Complement system in diseases (16 papers) and Systemic Lupus Erythematosus Research (4 papers). C. John Sperati is often cited by papers focused on Renal Diseases and Glomerulopathies (21 papers), Complement system in diseases (16 papers) and Systemic Lupus Erythematosus Research (4 papers). C. John Sperati collaborates with scholars based in United States, Canada and United Kingdom. C. John Sperati's co-authors include Priscilla K. Brastianos, Petros C. Karakousis, Jordan W. Swanson, Michael Torbenson, Alison R. Moliterno, Robert A. Brodsky, Michelle M. Estrella, Bernard G. Jaar, Xuan Yuan and James C. Stanley and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

C. John Sperati

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. John Sperati United States 19 411 345 308 248 232 52 1.3k
Y. Benhamou France 22 671 1.6× 415 1.2× 340 1.1× 458 1.8× 201 0.9× 123 1.8k
É. Alamartine France 26 254 0.6× 1.0k 3.0× 352 1.1× 198 0.8× 319 1.4× 85 2.0k
Norio Hanafusa Japan 26 139 0.3× 974 2.8× 278 0.9× 235 0.9× 383 1.7× 138 2.0k
Gema Fernández‐Fresnedo Spain 27 429 1.0× 637 1.8× 376 1.2× 118 0.5× 743 3.2× 116 2.3k
Julien Hogan France 22 321 0.8× 752 2.2× 267 0.9× 179 0.7× 144 0.6× 112 1.4k
Josef Kletzmayr Austria 28 252 0.6× 607 1.8× 174 0.6× 423 1.7× 530 2.3× 50 2.3k
L. Sailler France 24 261 0.6× 113 0.3× 467 1.5× 697 2.8× 389 1.7× 135 2.0k
Damien Noone Canada 20 326 0.8× 849 2.5× 260 0.8× 168 0.7× 141 0.6× 70 1.4k
Nada Alachkar United States 23 393 1.0× 907 2.6× 260 0.8× 78 0.3× 430 1.9× 56 1.8k
Éric Thervet France 28 349 0.8× 708 2.1× 580 1.9× 148 0.6× 569 2.5× 62 3.4k

Countries citing papers authored by C. John Sperati

Since Specialization
Citations

This map shows the geographic impact of C. John Sperati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. John Sperati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. John Sperati more than expected).

Fields of papers citing papers by C. John Sperati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. John Sperati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. John Sperati. The network helps show where C. John Sperati may publish in the future.

Co-authorship network of co-authors of C. John Sperati

This figure shows the co-authorship network connecting the top 25 collaborators of C. John Sperati. A scholar is included among the top collaborators of C. John Sperati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. John Sperati. C. John Sperati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cole, Michael, Gloria F. Gerber, George McNamara, et al.. (2024). Complement biosensors identify a classical pathway stimulus in complement-mediated thrombotic microangiopathy. Blood. 144(24). 2528–2545. 7 indexed citations
2.
Barratt, Jonathan, Adrian Liew, See Cheng Yeo, et al.. (2024). Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical Journal of the American Society of Nephrology. 19(4). 452–462. 28 indexed citations
3.
Johnson, Benjamin C., Laura Walsh, Diana Fang, et al.. (2024). A very complicated UTI: malakoplakia following E. coli urinary tract infection. BMC Nephrology. 25(1). 200–200.
4.
5.
Cervantes, C. Elena, Evan M. Bloch, & C. John Sperati. (2023). Therapeutic Plasma Exchange: Core Curriculum 2023. American Journal of Kidney Diseases. 81(4). 475–492. 33 indexed citations
6.
Podos, Steven D., Howard Trachtman, Gerald B. Appel, et al.. (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. American Journal of Nephrology. 53(10). 675–686. 11 indexed citations
7.
Zhang, Yuzhou, C. John Sperati, Kammi Henriksen, et al.. (2020). A Mutation in Complement Factor B Causing Massive Fluid-Phase Dysregulation of the Alternative Complement Pathway Can Result in Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology. 31(10S). 682–682.
8.
Tian, Xuefei, Kazunori Inoue, Yan Zhang, et al.. (2020). Inhibiting calpain 1 and 2 in cyclin G associated kinase–knockout mice mitigates podocyte injury. JCI Insight. 5(22). 15 indexed citations
9.
Yuan, Xuan, Jia Yu, Gloria F. Gerber, et al.. (2020). Ex vivo assays to detect complement activation in complementopathies. Clinical Immunology. 221. 108616–108616. 10 indexed citations
10.
Zhang, Yuzhou, C. John Sperati, Kammi Henriksen, et al.. (2020). Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome. Kidney International. 98(5). 1265–1274. 8 indexed citations
11.
Greer, Raquel C., Yang Liu, Kerri L. Cavanaugh, et al.. (2019). Primary Care Physicians’ Perceived Barriers to Nephrology Referral and Co-management of Patients with CKD: a Qualitative Study. Journal of General Internal Medicine. 34(7). 1228–1235. 48 indexed citations
12.
Vaishnav, Joban, et al.. (2019). Drug-Induced Hypertension. Endocrinology and Metabolism Clinics of North America. 48(4). 859–873. 19 indexed citations
13.
Vaught, Arthur J., Evan M. Braunstein, Jagar Jasem, et al.. (2018). Germline mutations in the alternative pathway of complement predispose to HELLP syndrome. JCI Insight. 3(6). 70 indexed citations
14.
Hanouneh, Mohamad, et al.. (2018). Renal vein thrombosis and pulmonary embolism. Cleveland Clinic Journal of Medicine. 85(11). 833–834. 2 indexed citations
15.
Sperati, C. John, et al.. (2017). The Hyperlipidemia Effect: Pseudohyponatremia in Pancreatic Cancer. The American Journal of Medicine. 130(12). 1372–1375. 6 indexed citations
16.
McMahon, Blaithin A., Robert A. Moran, C. John Sperati, et al.. (2016). Renal Thrombotic Microangiopathy, Podocytopathy, and Chylous Ascites: A Hard-Nosed Diagnosis. The American Journal of Medicine. 129(10). e227–e231. 1 indexed citations
17.
Gavriilaki, Eleni, Xuan Yuan, Zhaohui Ye, et al.. (2015). Modified Ham test for atypical hemolytic uremic syndrome. Blood. 125(23). 3637–3646. 77 indexed citations
18.
Olin, Jeffrey W., Heather L. Gornik, J. Michael Bacharach, et al.. (2014). Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions. Circulation. 129(9). 1048–1078. 261 indexed citations
19.
Vernon, Hilary J., Serena M. Bagnasco, Ada Hamosh, & C. John Sperati. (2013). Chronic Kidney Disease in an Adult with Propionic Acidemia. JIMD Reports. 12. 5–10. 12 indexed citations
20.
Sperati, C. John, et al.. (2008). Fibromuscular dysplasia. Kidney International. 75(3). 333–336. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Benhamou Breakdown of academic impact, for papers by É. Alamartine Breakdown of academic impact, for papers by Norio Hanafusa Breakdown of academic impact, for papers by Gema Fernández‐Fresnedo Breakdown of academic impact, for papers by Julien Hogan Breakdown of academic impact, for papers by Josef Kletzmayr Breakdown of academic impact, for papers by L. Sailler Breakdown of academic impact, for papers by Damien Noone Breakdown of academic impact, for papers by Nada Alachkar Breakdown of academic impact, for papers by Éric Thervet
Rankless by CCL
2026